FDA Seeks More Data on Sanofi-Aventis (France), Bristol-Myers Squibb Company’s Plavix

January 26, 2009 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

WASHINGTON, Jan 26 (Reuters) - U.S. health regulators said on Monday they are reviewing the effectiveness of the widely used blood thinner Plavix, made by Sanofi-Aventis SA (SASY.PA) and Bristol-Myers Squibb Co (BMY.N), in some patients.

Twitter
LinkedIn
Facebook
Email
Print

Clinical research Postmarket research

Bristol Myers Squibb Company Food and Drug Administration (FDA) Sanofi (France)